Literature DB >> 22264638

Reconstruction with Vertical Rectus Abdominus Myocutaneous flap in advanced pelvic malignancy.

Terrence A Creagh1, Liane Dixon, Frank A Frizelle.   

Abstract

Pelvic extenuative surgery produces good long term outcomes in advanced pelvic malignancies. We evaluate the use and clinical outcomes of the Vertical Rectus Abdominus Myocutaenous (VRAM) flap as a reconstruction technique in a heterogenic cohort of patients with advanced colorectal cancer in whom neo-adjuvant chemo-radiotherapy had been performed pre-operatively. Analysis of patients having VRAM flaps for pelvic reconstruction in a tertiary referral centre from 2001 to 2010 was conducted. 37 patients (23 female, 14 male) underwent pelvic extenuative surgery of which 22 (60%) had recurrent pelvic disease. All surgical and medical complications were analysed. Major flap complications were defined as 'requiring return to the operating theatre at any stage' and these occurred in 6 (16%) patients. There were 7 (19%) minor flap complications defined as 'requiring conservative non surgical treatment' The total global re-intervention rate of patients requiring return to theatre for re-operation as a result of their exenteration and reconstruction was 6 (16%). We highlight the merits and versatility of the VRAM flap in advanced pelvic malignancy in obtaining stable and supple reconstructive cover and the relative low morbidity in this difficult group confirms out strong support for immediate VRAM reconstruction in pelvic exenterative procedures. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22264638     DOI: 10.1016/j.bjps.2011.11.063

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  8 in total

1.  A hundred patients with vertical rectus abdominis myocutaneous (VRAM) flap for pelvic reconstruction after total pelvic exenteration.

Authors:  R E Horch; W Hohenberger; A Eweida; U Kneser; K Weber; A Arkudas; S Merkel; J Göhl; J P Beier
Journal:  Int J Colorectal Dis       Date:  2014-04-22       Impact factor: 2.571

2.  Vertical rectus abdominis myocutaneous flap and quality of life following abdominoperineal excision for rectal cancer: a multi-institutional study.

Authors:  V O'Dowd; J P Burke; E Condon; D Waldron; N Ajmal; J Deasy; D A McNamara; J C Coffey
Journal:  Tech Coloproctol       Date:  2014-05-07       Impact factor: 3.781

3.  Complications, secondary interventions and long term morbidity after en bloc sacrectomy.

Authors:  J J Verlaan; J S Kuperus; W B Slooff; A Hennipman; F C Oner
Journal:  Eur Spine J       Date:  2014-12-27       Impact factor: 3.134

4.  Time to Chemotherapy After Abdominoperineal Resection: Comparison Between Primary Closure and Perineal Flap Reconstruction.

Authors:  Azah A Althumairi; Joseph K Canner; Nita Ahuja; Justin M Sacks; Bashar Safar; Jonathan E Efron
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

5.  Use of the anterolateral thigh and vertical rectus abdominis musculocutaneous flaps as utility flaps in reconstructing large groin defects.

Authors:  Edwin Jonathan Aslim; Mohamed Zulfikar Rasheed; Fangbo Lin; Yee-Siang Ong; Bien-Keem Tan
Journal:  Arch Plast Surg       Date:  2014-09-15

6.  VRAM-pedicled island flap for the coverage of an exposed prosthetic vascular graft in the suprapubic area.

Authors:  C Rubino; M Faenza; N Campitiello; G Fornino; F Santanelli di Pompeo; G C Accarino
Journal:  Case Reports Plast Surg Hand Surg       Date:  2016-07-18

7.  Intestinal obstruction following harvest of VRAM-flap for reconstruction of a large perineal defect.

Authors:  Sherif Elawa; Olof Hallböök; Pär Myrelid; Johann Zdolsek
Journal:  Case Reports Plast Surg Hand Surg       Date:  2015-12-11

8.  Donor Site Morbidity of Patients Receiving Vertical Rectus Abdominis Myocutaneous Flap for Perineal, Vaginal or Inguinal Reconstruction.

Authors:  Vera S Schellerer; Lenka Bartholomé; Melanie C Langheinrich; Robert Grützmann; Raymund E Horch; Susanne Merkel; Klaus Weber
Journal:  World J Surg       Date:  2020-09-29       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.